INTELLIGENT TECHNOLOGY

SOFTWARE

Tracxn has released its In-Space Manufacturing Report 2026, offering a data-driven perspective on the evolution of the global ISM start-ups ecosystem across company formation trends, commercialization pathways, funding dynamics, investor participation, geographic concentration and exit activity.

Among the report’ s highlights are:

• The United States dominates global investment with ~ 85 % funding share.

• The global in-space manufacturing( ISM) ecosystem comprises 15 + startups, reflecting a structurally pre-scale market shaped by long development cycles, infrastructure dependency and high capital intensity.

• All-time equity funding has reached ~ US $ 397M, but capital deployment remains episodic and concentrated, with Varda Space Industries’ US $ 187m Series C accounting for 82 % of 2025 funding from a single round, signaling selective investor conviction rather than broad-based sector expansion.

• High-value microgravity manufacturing is emerging as the nearest-term commercialization pathway, while in-orbit assembly and infrastructure platforms represent longer-horizon industrial positioning bets.

• Exit pathways remain nascent, with one acquisition recorded to date and no IPOs, underscoring that liquidity remains driven by strategic consolidation rather than demandvalidated commercial maturity.

As of March 2026 YTD, the sector remains structurally early, with technological feasibility increasingly validated but sustained industrial deployment still dependent on infrastructure continuity, launch cadence reliability and repeatable commercial demand.

The global ISM ecosystem has attracted approximately US $ 397m in all-time equity funding across 22 rounds, reflecting selective rather than broad investor participation. Capital deployment has been volatile and milestone-driven, with funding peaking at US $ 227m in 2025 – largely driven by a single mega round, Varda Space Industries’ US $ 187m Series C.

This concentration signals a structural shift in investor behaviour, where funding is consolidating behind technically credible operators demonstrating progress toward scalable orbital production, even as earlystage players continue to compete for a relatively thin pool of exploratory capital.

Stage-wise funding trends indicate that the ecosystem is gradually progressing from seed-dominated experimentation toward selective scale financing. While most rounds remain concentrated at the seed stage, 2025 marked the first meaningful appearance of late-stage capital, signaling early but directionally important ecosystem maturation.

However, the narrow distribution of late-stage funding suggests that scaling remains confined to a small cohort of startups capable of navigating the sector’ s steep technical and capital thresholds.

Commercial positioning across the ISM landscape reflects divergent monetization timelines. High-value microgravity manufacturing, particularly in pharmaceuticals and specialty materials, is emerging as the most viable near-term opportunity, driven by the value-density thesis where performance premiums can offset orbital production costs.

In contrast, in-orbit assembly and enabling infrastructure platforms, including commercial station modules and reusable return vehicles, represent longer-horizon bets tied to the broader expansion of the orbital economy.

Geographically, capital formation remains highly concentrated. The US accounts for approximately US $ 337m(~ 85 %) of alltime funding, supported by deep venture ecosystems, government alignment and early commercial proof points.

Exit activity remains limited, with only one acquisition recorded, Made In Space’ s acquisition by Redwire Space in 2020, and no IPOs to date. This reflects the sector’ s position within the deep-tech commercialization lifecycle, where liquidity typically emerges first through strategic consolidation before public market participation becomes viable.

As operators progress toward repeatable commercial missions, acquisition activity is expected to remain the dominant near-term exit pathway. Looking ahead, the trajectory of in-space manufacturing will be shaped less by technological feasibility and more by ecosystem synchronization across launch economics, orbital infrastructure continuity, regulatory integration and sustained customer demand validation.

Near-term milestones include repeated multi-mission production cycles and regulatory approvals in sectors such as pharmaceuticals, while long-term scalability will depend on the successful deployment of private space stations and diversification of launch providers. •

30

INTELLIGENT CIO NORTH AMERICA www. intelligentcio. com